Skip to main content

New Perspectives on Melanoma Pathogenesis and Chemoprevention

  • Conference paper

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 174))

Abstract

Epidemiologic studies implicate ultraviolet radiation (sunlight) as an etiologic agent for the pathogenesis of melanoma. However, the experimental evidence is less convincing. We present information from recent experimental findings that elevation of reactive oxygen species follows from melanin serving as a redox generator, and that this may play an important role in the etiology and pathogenesis of cutaneous melanoma. These observations offer a new paradigm for the development of preventive (and therapeutic) approaches to this disease.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Austin DF, Reynolds P (1986) Occupation and malignant melanoma of the skin. Recent Results Cancer Res 102:98–107

    PubMed  CAS  Google Scholar 

  • Berwick M, Armstrong BK, Ben-Porat L, Fine J, Kricker A, Eberle C, Barnhill R (2005) Sun exposure and mortality from melanoma. J Natl Cancer Inst 97:195–199

    Article  PubMed  Google Scholar 

  • Cen D, Gonzalez R, Buckmeier J, Kahlon R, Tohidian NB, Meyskens FL Jr (2002) Disulfiram induces apoptosis in human melanoma cells: a redox-related process. Mol Cancer Ther 1:197–204

    PubMed  CAS  Google Scholar 

  • Cen D, Brayton D, Shahandeh B, Meyskens FL Jr (2004) Farmer PDisulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells. J Med Chem 47:6914–6920

    Article  PubMed  CAS  Google Scholar 

  • Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Brocker EB, LeBoit PE, Pinkel D, Bastian BC (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353:2135–2147

    Article  PubMed  CAS  Google Scholar 

  • Farmer PJ, Gidanian S, Shahandeh B, Di Bilio AJ, Tohidian N, Meyskens FL Jr (2003) Melanin as a target for melanoma chemotherapy: Pro-oxidant effect of oxygen and metals on melanoma viability. Pigment Cell Res 16:273–279

    Article  PubMed  CAS  Google Scholar 

  • Farmer PJ, Brayton D, Moore C, Williams D, Shahandeh B, Cen D, Meyskens FL Jr (2005) Targeting melanoma via metal-based stress. In: Sessle JL, Doctrow SR, McMurray TJ, Lippard SJ (eds) Medicinal inorganic chemistry. 903:400–414

    Google Scholar 

  • Gidanian S, Farmer PJ (2002) Redox behavior of melanins: direct electrochemistry of dihydroxyindolemelanin and its Cu and Zn adducts. J Inorg Biochem 89:54–60

    Article  PubMed  CAS  Google Scholar 

  • Ha L, Noonan FP, De Fabo EC, Merlino G (2005) Animal models of melanoma. J Investig Dermatol Symp Proc 10:86–88

    Article  PubMed  CAS  Google Scholar 

  • Jimbow K, Horikoshi T, Takahashi H, Akutsu Y, Maeda K (1989) Fine structural and immunohistochemical properties of dysplastic melanocytic nevi: comparison with malignant melanoma. J Invest Dermatol 92[Suppl]:304S–309S

    Article  PubMed  CAS  Google Scholar 

  • Loomis D, Browning SR, Schenck AP, Gregory E, Savitz DA (1997) Cancer mortality among electric utility workers exposed to polychlorinated biphenyls. Occup Environ Med 54:720–728

    Article  PubMed  CAS  Google Scholar 

  • Meyskens FL Jr (2003) Management of Human Melanoma: What has the last decade wrought? Oncologist 8:448–450

    Article  PubMed  Google Scholar 

  • Meyskens FL Jr, Chau V, Tohidian N, Buckmeier J (1997) Luminol-enhanced Chemiluminescent response of human melanocytes and melanoma cells to Hydrogen Peroxide Stress. Pigment Cell Res 10:184–189

    Article  PubMed  CAS  Google Scholar 

  • Meyskens FL Jr, Buckmeier JA, Tohidian NB (1999) Activation of nuclear factor-κB in human metastatic melanoma cells and the effect of oxidative stress. Clin Cancer Res 5:1197–1202

    PubMed  CAS  Google Scholar 

  • Meyskens FL Jr, McNulty SE, Buckmeier JA, Tohidian NB, Spillane TJ, Kahlon RS, Gonzalez RI (2001) Aberrant redox regulation in human metastatic Melanoma cells compared to normal melanocytes. Free Radical Biol Med 31:799–808

    Article  CAS  Google Scholar 

  • Meyskens FL Jr, Farmer P, Anton-Culver H (2004) Etiologic pathogenesis of melanoma: a unifying hypothesis for the missing attributable risk. Clin Cancer Res 10:2581–2583

    Article  PubMed  CAS  Google Scholar 

  • McNulty S, Tohidian NB, Meyskens FL Jr (2001) Rel A, p50 and inhibitor of kappa B alpha are elevated in human metastatic melanoma cells and respond aberrantly to ultraviolet light B. Pigment Cell Res 14:456–465

    Article  PubMed  CAS  Google Scholar 

  • McNulty S, del Rosario R, Cen D, Meyskens FL Jr, Yang S (2004) Comparative expression of NFkB proteins in melanocytes of normal skin vs. benign intradermal naevus and human metastatic melanoma biopsies. Pigment Cell Research 17:173–180

    Article  PubMed  CAS  Google Scholar 

  • Millen AE, Tucker MA, Hartge P, Halpern A, Elder DE, Guerry D 4th, Holly EA, Sagebiel RW, Potischman N (2004) Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev 13:1042–1051

    PubMed  CAS  Google Scholar 

  • Omenn GS, Goodman G, Grizzle J, Thornquist M, Meyskens FL Jr et al (1991) CARET, the β-carotene and retinol efficacy trial to prevent lung cancer in asbestos-exposed workers and in smokers. Anti-Cancer Drugs 2:79–86

    Article  PubMed  CAS  Google Scholar 

  • Rhodes AR, Seki Y, Fitzpatrick TB, Stern RS (1988) Melanosomal alterations in dysplastic melanocytic nevi. A quantitative, ultrastructural investigation. Cancer 61:358–369

    Article  PubMed  CAS  Google Scholar 

  • Weinlich G, Eisendle K, Hassler E, Baltaci M, Fritsch PO, Zelger B (2006) Metallothionein — overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients. Br J Cancer 94:835–841

    Article  PubMed  CAS  Google Scholar 

  • Wolnicka-Glubisz A, Noonan FP (2006) Neonatal susceptibility to UV induced cutaneous malignant melanoma in a mouse model. Photochem Photobiol Sci 5:254–260

    Article  PubMed  CAS  Google Scholar 

  • Yang S, McNulty S, Meyskens FL Jr (2004) During human melanoma progression AP-1 binding pairs are altered with loss of c-Jun in vitro. Pigment Cell Res 17:74–83

    Article  PubMed  CAS  Google Scholar 

  • Yang S, Meyskens FL Jr (2005) Alteration in activating protein 1 (AP-1) composition correlate with phenotypic differentiation changes induced by resveratrol in human melanoma. Mol Pharmacol 67:298–308

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Meyskens, F.L., Farmer, P.J., Yang, S., Anton-Culver, H. (2007). New Perspectives on Melanoma Pathogenesis and Chemoprevention. In: Senn, HJ., Kapp, U. (eds) Cancer Prevention. Recent Results in Cancer Research, vol 174. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-37696-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-37696-5_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-37695-8

  • Online ISBN: 978-3-540-37696-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics